Benzinga's Top Upgrades, Downgrades For April 2, 2018

Top Upgrades

• Deutsche Bank upgraded J.B. Hunt Transport Services, Inc. JBHT from Hold to Buy. Hunt shares rose 1.94 percent to close at $117.15 on Thursday.
• Wells Fargo upgraded Discovery Communications, Inc. DISCA from Market Perform to Outperform. Discovery shares rose 1.23 percent to close at $21.43 on Thursday.
• Analysts at RBC Capital upgraded Automatic Data Processing, Inc. ADP from Sector Perform to Outperform. ADP rose 1.24 percent to $114.89 in pre-market trading.
• BMO Capital upgraded Greif, Inc. GEF from Market Perform to Outperform. Greif shares fell 0.38 percent to $52.05 in pre-market trading.
• Goldman upgraded Northern Trust Corporation NTRS from Neutral to Buy. Northern Trust shares rose 0.65 percent to $103.80 in pre-market trading.
• Deutsche Bank upgraded Union Pacific Corporation UNP from Hold to Buy. Union Pacific shares rose 2.81 percent to close at $134.43 on Thursday.
• Jefferies upgraded Tesla, Inc. TSLA from Underperform to Hold. Tandem Diabetes Care shares fell 4.46 percent to $254.25 in pre-market trading.
• Keefe, Bruyette Woods upgraded Allstate Corporation ALL from Underperform to Market Perform. Allstate shares rose 0.20 percent to close at $94.80 on Thursday.
• RBC Capital upgraded Paychex, Inc. PAYX from Underperform to Sector Perform. Paychex shares rose 1.63 percent to close at $61.59 on Thursday.
• Bank of America upgraded Baker Hughes, a GE company BHGE from Neutral to Buy. Baker Hughes shares rose 1.22 percent to $28.11 in pre-market trading.

Top Downgrades

• Morgan Stanley downgraded Fitbit, Inc. FIT from Equal-Weight to Underweight. Fitbit shares fell 5.29 percent to $4.83 in pre-market trading.
• Bank of America downgraded Sonoco Products SON from Buy to Neutral. Sonoco shares fell 1.13 percent to $47.95 in pre-market trading.
• Analysts at Baird downgraded National Instruments Corporation NATI from Outperform to Neutral. National Instruments shares rose 2.68 percent to close at $50.57 on Thursday.
• Barclays downgraded XL Group Ltd XL from Overweight to Equal-Weight. XL shares fell 0.16 percent to close at $55.26 on Thursday.
• Bank of America downgraded Greif, Inc. GEF from Buy to Neutral. Greif shares fell 0.38 percent to $52.05 in pre-market trading.
• Bank of America downgraded Domtar Corporation UFS from Buy to Neutral. Domtar shares fell 1.27 percent to $42.00 in pre-market trading.
• Raymond James downgraded RSP Permian, Inc. RSPP from Strong Buy to Market Perform. RSP Permian shares rose 4.18 percent to close at $46.88 on Thursday.

Top Initiations

• Ascendiant Capital initiated coverage on IsoRay, Inc. ISR with a Buy rating. The price target for IsoRay is set to $1. IsoRay shares closed at $0.4206 on Thursday.
• Analysts at H.C. Wainwright initiated coverage on SELLAS Life Sciences Group, Inc SLS with a Buy rating. The price target for SELLAS Life Sciences is set to $11. SELLAS Life Sciences closed at $3.45 on Thursday.
• Barclays initiated coverage on BioXcel Therapeutics, Inc. BTAI with an Overweight rating. The price target for BioXcel Therapeutics is set to $15. BioXcel Therapeutics shares closed at $10.24 on Thursday.
• H.C. Wainwright assumed coverage on Nektar Therapeutics NKTR with a Buy rating. The price target for Nektar Therapeutics is set to $125. Nektar Therapeutics shares closed at $106.26 on Thursday.
• Analysts at Canaccord Genuity initiated coverage on BioXcel Therapeutics, Inc. BTAI with a Buy rating. The price target for BioXcel Therapeutics is set to $21. BioXcel Therapeutics shares closed at $10.24 on Thursday.